2023
conference-abstract
OpenAlex
Keila Cristina Miranda, Aléxia Polo Siqueira, Maria Fernanda Santiago Gonçalves, Isabella Lemuqui Tegami et autres
Background: Early-stage non-small cell lung cancer(NSCLC) present high rates of recurrence, even undergoing curative treatment such as surgery and/or adjuvant chemotherapy(ACT). Specific criteria lack to define a therapeutic approach that offers the maximum survival benefit for prognosis improvement. Aim: To validate a …
br, pt
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Isabella Lemuqui Tegami, Luciane Sussuchi da Silva, Rodrigo de Oliveira Cavagna, Maria Fernanda Santiago Gonçalves et autres
br, pt
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Pedro de Marchi, Letícia Ferro Leal, Luciane Sussuchi da Silva, Rodrigo de Oliveira Cavagna et autres
All articles of this category (opens in new window)
Accès ouvert
2021
article
OpenAlex
Icaro Alves Pinto, Rodrigo de Oliveira Cavagna, Aline Larissa Virginio da Silva, Josiane Mourão Dias et autres
All articles of this category (opens in new window)
br
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Maria Fernanda Santiago Gonçalves, Luciane Sussuchi da Silva, Yin Shen, Pedro Rafael Martins De Marchi et autres
All articles of this category (opens in new window) Introduction: Lung cancer is the deadliest cancer worldwide with very low survival rates. Curative treatments are available for early-stage patients with non-small cell lung cancer (NSCLC), including both surgery and adjuvant chemotherapy. However, …
br, us
(code pays fourni par la source)